All patients and/or their parents or legal guardians must sign a written informed consent

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Subject has given written informed consent

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines.

Patients must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines; for step 1 initial registration, the appropriate consent form is the step 1 consent form

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines; the appropriate consent form for this registration is the step 2 consent form

STEP 3 CROSSOVER REGISTRATION (OPTIONAL): Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines; the appropriate consent form for this registration is the step 2 consent form

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

REGISTRATION STEP 2-RANDOMIZATION: Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent for this protocol in accordance with institutional and federal guidelines

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Patient must have given written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent.

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

All patients and/or their parents or legal guardians must sign a written informed consent

Patients must have signed an approved informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

All patients and/or their parents or legal guardians must sign a written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent

All patients and/or their parent or legal guardian must sign a written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent

Each patient’s parents or legal guardians must sign a written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent

Written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

All patients and/or their parents or legal guardians must sign a written informed consent

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patient must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

ALL PATIENTS: Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legal guardians must sign a written informed consent

Ability to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Voluntary written informed consent

Patients with mental deficits or psychiatric conditions that preclude them from giving informed consent or following protocol

Informed Consent: All subjects and/or legal guardians must sign informed written consent. Assent, when appropriate, will be obtained according to institutional guidelines.

Willing and able to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information; NOTE: HIPAA authorization may be either included in the informed consent or obtained separately; consent and HIPPA authorization must be obtained prior to any screening procedures

Voluntary agreement to provide written informed consent and the willingness and ability to comply with all aspects of the protocol

Signed written informed consent must be obtained and documented according to International Conference on Harmonisation (ICH) and local regulatory requirements

All patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Written informed consent which is consistent with International Conference on Harmonization - Good Clinical Practice (ICH-GCP) guidelines and local legislation.

Informed Consent: All subjects and/or legal guardians must sign informed written consent. Assent, when appropriate, will be obtained according to institutional guidelines

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

The patient must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must have signed an authorization for the release of their protected health information

All patients and/or their parents or legal guardians must sign a written informed consent

Informed consent must be obtained according to St. Jude guidelines before enrollment into study

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Signed and dated voluntary written informed consent before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Any HSCT within 6 months prior to signing informed consent

Subject has voluntarily agreed to participate by giving written informed consent in accordance with ICH GCP Guidelines and applicable local regulations.

At least 18 or older of age on day of signing informed consent

Documented informed consent

Voluntary written informed consent and HIPAA authorization and agree to comply with all protocol-specified procedures and follow-up evaluations

Voluntary agreement to provide written informed consent and the willingness and ability to comply with all aspects of the protocol

Patients must give informed consent prior to initiation of therapy

Ability to provide written informed consent in accordance with federal, local, and institutional guidelines

Subject must have a brain scan performed during Screening or within 3 months prior to signing informed consent;

Willing and able to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information; NOTE: HIPAA authorization may be either included in the informed consent or obtained separately

Any perceived inability to directly (and without the means of a legal guardian) provide informed consent

SAFETY RUN-IN: Signed written informed consent in accordance with regulatory and institutional guidelines

RANDOMIZED PHASE II CLINICAL TRIAL: Signed written informed consent in accordance with regulatory and institutional guidelines

Potential subject must have the ability to understand (as judged by the treating physician) and willingness to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information\r\n* NOTE: HIPAA authorization may be included in the informed consent or obtained separately; written informed consent must be obtained from a potential subject prior to the conduct of any study-specific procedures

Patients have voluntarily agreed to participate by giving written informed consent.

Voluntary written informed consent

Informed consent/assent

Execute an informed consent.

Voluntary written consent must be signed before performance of any study related procedure not part of standard medical care, with the understanding that the subject may withdraw consent at any time without prejudice to future medical care

Subjects unable to comprehend and give informed consent are excluded.

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that the patient may withdraw consent at any time without prejudice to future medical care

Written and voluntary informed consent.

Written informed consent

Voluntary written informed consent before performance of any study-related procedure not part of routine medical care with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Written informed consent

Capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent; in patients who are not able to consent to the trial due to medical circumstances, the next of kin or power of attorney may consent for the study

Provided informed consent

Capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent

Written informed consent in accordance with federal, local, and institutional guidelines

Written informed consent in accordance with federal, local, and institutional guidelines

Patients must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects; patients will be given a copy of the consent form

Patients must agree, as part of the informed consent, to provide blood for pharmacokinetics analysis

The subject or subject's medical power of attorney has provided written consent to participate in this study.

Ability to give informed consent.

Have mental deficits and/or psychiatric history that may compromise the ability to give written informed consent or to comply with the study protocol.

Subject is ? 18 years of age at the time of signing the informed consent form (ICF).

Be capable, willing, and able to provide written informed consent/assent. For patients < 18 years of age, their parents or legal guardians must sign a written informed consent. Assent, when appropriate, will be obtained according to institutional guidelines.

A patient must be capable of giving informed consent or have an acceptable surrogate capable of giving consent on the subject’s behalf

Legal incapacity/limited legal capacity for providing informed consent.

Ability to understand the nature of this study and give written informed consent.

Ability to give informed consent; all subjects >= 18 years of age must be able to give informed consent; for subjects < 18 years old their legal authorized representative (LAR) (i.e. parent or guardian) must give informed consent; pediatric subjects will be included in age appropriate discussion and verbal assent will be obtained for those > 7 years of age, when appropriate

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Ability to understand and the willingness to sign an informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Informed consent cannot be obtained either from the patient or legal representative

Documented informed consent of participant and/or legally authorized representative

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information prior to registration; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Written informed consent has been obtained

Informed and must sign and give written informed consent in accordance with institutional and federal guidelines

Provided written informed consent and HIPAA authorization for release of personal health information, approved by an Institutional Review Board (IRB). NOTE: HIPAA authorization may be included in the informed consent or obtained separately.

Any mental or medical condition that prevents the subject from giving informed consent or participating in the trial.

Patients must have the psychological ability and general health that permits informed consent, completion of the study requirements, and required follow up

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Written informed consent following Institutional Review Board, National Cancer Institute (NCI), Food and Drug Administration (FDA), and Office for Human Research Protections (OHRP) guidelines

Inability or unwillingness of legal guardian/representative to give written informed consent

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care.

Provision of informed consent

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care.

For inclusion in optional genetic research, the patient must provide a written informed consent for genetic research.

Written informed consent prior to any procedure.

Patient must sign an informed consent document indicating that they are aware of the investigational nature of this study, which includes an authorization for the release of their protected health information

Patient and/or legal guardian must sign informed consent for HSCT.

Ability to understand and the willingness to sign a written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Patients with mental deficits and/or psychiatric history that preclude them from giving informed consent or from following protocol

Subjects or their legally authorized representative must be informed of the investigational nature of this study, and must sign and give written informed consent in accordance with institutional and federal guidelines

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

The patient has given written informed consent after the nature of the study and alternative treatment options have been explained

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Informed Consent: All subjects and/or legal guardians must sign informed written consent. Assent, when appropriate, will be obtained according to institutional guidelines.

Informed consent provided

Provides written informed consent on the approved informed consent form

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Patient or parent/guardian capable of providing informed consent

Patient or parent/guardian capable of providing informed consent

All subjects must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Diagnostic or laboratory studies performed exclusively to determine eligibility for this trial must only be done after obtaining written informed consent from all patients, which can be accomplished using the NCI, POB screening protocol; studies or procedures that were performed for clinical indications (not exclusively to determine eligibility) may be used for screening or baseline values even if the studies were done before informed consent was obtained, if the patient agrees

Paediatric patients aged 2 years to <18 years at the time of informed consent

Patients, parents/guardian(s), legally authorized representative (LAR), or durable power of attorney must be able to give consent and sign the informed consent document; pediatric subjects will be included in age appropriate discussion and verbal assent will be obtained for those > 7 years of age, when appropriate

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Patients must give voluntary written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization before performance of any study-related procedure not part of normal medical care with the understanding that consent maybe withdrawn by the subject at any time without prejudice to future medical care

ELIGIBILITY FOR SCREENING: Informed consent (and assent as applicable) obtained from patient/guardian

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Voluntary written consent must be given before performance of any study-related procedures not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

No written consent of the patient or his/her parents or legal guardian

Informed consent must be obtained from all patients prior to beginning therapy, including consent for mandatory tissue submission for ERCC1 staining (and p16 staining if not locally conducted); patients should have the ability to understand and the willingness to sign a written informed consent document

Patients or legal guardians must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects; patients or their guardians will be given a copy of the consent form

All patients must be informed of the investigational nature of this study and given written informed consent in accordance with institutional and federal guidelines

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care

Written informed consent provided.

All participants and/or their parents or legal guardians must sign a written informed consent

Unwillingness to give written informed consent

Patient must be at least 18 years old at the time of consent.

Must be capable of giving consent to participate in the study

Patients who give a written informed consent obtained according to local guidelines

Inability or unwillingness of research participant or legal guardian/representative to give written informed consent

Provided written informed consent

Has provided written informed consent for participation in this trial

Cognitively impaired patients who cannot give informed consent and do not have a legal guardian

Subject has provided written informed consent

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

The patient or their legal guardian must give their informed consent

Willing to give informed consent\r\n* A parent or guardian must be available for giving consent for pediatric subjects under 18 years of age

Ability to understand and the willingness to sign a written informed consent document. Patients with Impaired Decision Making Capacity (IDMC) can have a Legally Authorized Representative sign on their behalf. Documentation, such as a Power of Attorney, must be presented in order for a substitute decision maker to be allowed

Willing and able to provide written informed consent (ICF) and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information. A signed informed consent must be obtained before screening procedures are performed\r\n* NOTE: HIPAA authorization may be either included in the informed consent or obtained separately

Written informed consent obtained to participate in the study and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information. Consent for the use of any residual material from biopsy (archival tissue) and serial blood draws will be required for enrollment.

Inability or unwillingness or research participant or legal guardian/representative to give written informed consent

Ability to give written informed consent

Have the capacity to give informed consent

All subjects must have the ability to understand and the willingness to sign a written informed consent; they are to give voluntary written informed consent before performance if any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care; cognitively impaired subjects will be included only if their guardian or legal representative agrees to sign the written informed consent

Signed written informed consent: voluntary written consent must be given before performance of any study-related procedure not part of standard medical care

Subjects given written informed consent

Give informed consent

Refuses to give informed consent

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization (applies to covered entities in the Unites States of America [USA] only) obtained from the subject/legal representative prior to performing any protocol-related procedures, including screening evaluations.

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information prior to registration. NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Subjects must be willing and able to provide informed consent. For patients < 18 years of age, their parents or legal guardians must sign a written informed consent. Assent, when appropriate, will be obtained according to institutional guidelines.

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information prior to registration. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.

Ability of subject or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document; for subjects < 18 years old their legal guardian must give informed consent; pediatric subjects will be included in age appropriate discussion and verbal assent will be obtained for those > 7 years of age, when appropriate

Has any mental or medical condition that prevents the patient from giving informed consent or participating in the trial

Voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Willing and able to provide written informed consent and Authorization for Use and Release of Health and Research Study Information (HIPAA authorization)\r\n* NOTE: HIPAA authorization may be either included in the informed consent or obtained separately

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care.

Unable to give informed consent

For inclusion in the optional PGx research, patients must provide informed consent for the genetic sampling and analyses.

Evidence of a personally signed informed consent indicating that the subject is aware of the neoplastic nature of the disease and has been informed of the procedures to be followed, the experimental nature of the therapy, alternatives, potential risks and discomforts, potential benefits, and other pertinent aspects of study participation.

Men and women ?18 years old on the day of signing informed consent.

Written informed consent and authorization for release of personal health information obtained according to local laws.

Provision of written informed consent

Ability to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization. This will be assessed by the consenting physician using general questions as outlined in Etchell’s 1999 publication titled Assessment of Patient Capacity to Consent to Treatment. These are general conversation based questions that assess the patient’s ability to understand the medical problem, proposed treatment, alternatives to proposed treatment, and understand the consequences of the medical choices

The subject (or legally acceptable representative if applicable) provides written informed consent for the trial. The subject may also provide consent for future biomedical research. However the subject may participate in the main trial without participating in future biomedical research.

Signed and dated written informed consent prior to admission to the study in accordance with International Conference on Harmonization-Good Clinical Practice (ICH-GCP) guidelines and to the local legislation.

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Ability to understand the nature of this trial and give written informed consent.

All patients >= 18 years of age must sign a written informed consent; for patients < 18 years old, the patient’s parents or legal guardians must sign a written informed consent, unless the patient is an emancipated minor; childhood assent, when age appropriate as per institutional guidelines, should be signed by the participating patient

Informed consent for participation

Written informed consent must be obtained from the patient.

Documented informed consent of participant and/or legally authorized representative

Written informed consent.

All patients and/or a legal guardian must sign institutionally approved written informed consent and assent documents

Written informed consent and authorization obtained from the subject/Health Insurance Portability and Accountability Act (HIPAA)-appointed legal representative prior to performing any protocol-related procedures including screening evaluations

Patient has a psychiatric illness that would prevent the patient or legal guardian or representative from giving informed consent and/or assent.

Have the capacity to give informed consent

Ability to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Patients and/or their parents or legal guardians must be capable of understanding the investigational nature, potential risks and benefits of the study; all patients and/or their parents or legal guardians must sign a written informed consent

Have provided written informed consent

Ability to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Has the ability to give informed consent, or for cognitively or decisionally impaired individuals (vulnerable population), the availability of a family member or guardian to give consent and assist in the consent process

Patients must be capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form.

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Patients must be capable of understanding and providing a written informed consent

Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution. Patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy.

All patients must be informed of the investigational nature of this study and have given written consent in accordance with institutional and federal guidelines

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information

Written informed consent (or assent/ parental consent for minor subjects) prior to any screening procedures

Informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information obtained

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Voluntary written consent signed before performance of any study-related procedure not part of normal medical care

Subject is 1 to < 21 years of age at the time of signing the Informed Consent Form/Informed Assent Form (ICF/IAF).

Subjects must be informed of the investigational nature of this study, and must sign and give written informed consent in accordance with institutional and federal guidelines.

At least 18 years old at the time of informed consent

All participants and/or their parents or guardians must sign a written informed consent.

Must have provided written informed consent prior to participating in any study-related activity.

Voluntary agreement to provide written informed consent and the willingness and ability to comply with all aspects of the protocol

Written informed consent in accordance with federal, local, and institutional guidelines

All patients must be informed of the investigational nature of this study and must be given written informed consent in accordance with institutional and federal guidelines

Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution. Patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy

Subjects must give informed consent according to the rules and regulations of the individual participating sites.

Written informed consent.

Understand and able to willingly provide voluntary written informed consent, with the understanding that consent may be withdrawn by the subject at any time without prejudice to their future medical care

Patient is ? 18 years old at the time of informed consent.

Ability to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Written informed consent

Willing and able to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information

Have provided written consent for protocol directed biopsies

Signed and dated written informed consent must be provided by the patient prior to admission to the study in accordance with International Conference on Harmonization-Good Clinical Practice (ICH-GCP) guidelines and to the local legislation

Patients or appropriate legally authorized representatives must possess the ability to give informed consent

Documented informed consent of the participant or legally authorized representative

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Inability to understand or give an informed consent

Voluntary written consent

DONOR: Documented informed consent per local, state and federal guidelines

Written, informed consent and assent following Institutional Review Board, National Cancer Institute (NCI), Food and Drug Administration (FDA), and Office for Human Research Protections (OHRP) guidelines

Inability or unwillingness of research participant or legal guardian/representative to give written informed consent

Patients must be informed of investigational nature of this study and must be willing to give written informed consent in accordance with institutional and federal guidelines. Patients must be able to comply with the requirements and assessments of the study protocol

Written informed consent in accordance with federal, local, and institutional guidelines. The patient must provide informed consent prior to the first screening procedure. However, the Investigator should not repeat procedures that are performed as part of standard of care (SOC), if they are within the screening window and are done prior to signing the informed consent form (ICF)

Voluntary signed informed consent before performance of any study related procedure not part of normal medical care indicating that the patient is aware of the investigation and nature of this study in keeping with institutional policies and with the understanding that the consent may be withdrawn with the subject at any time without prejudice to future medical care

Written informed consent and Health Insurance Portability and Accountability Act of 1996 (HIPAA) authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of protected health information; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

The patient must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts

Have provided written informed consent.

Ability to give informed consent

Willing and able to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information; provision of informed consent prior to any study procedures\r\n* NOTE: HIPAA authorization may be either included in the informed consent or obtained separately

Signing of the Informed Consent Form

Psychiatric disorder that would preclude patients from signing an informed consent

Capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form

PRE-SCREENING: Written informed consent for prescreening

FULL STUDY INCLUSION CRITERIA: Written informed consent for full study

Ability to give informed consent and comply with the protocol

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study. Patients must have signed an authorization for the release of their protected health information. Patients must be registered prior to treatment on study.

Provision of genetics research informed consent

All patients must be capable to voluntarily sign an informed consent indicating that they are aware of the investigational nature of this study prior to registration

Voluntary written consent

Patient, or patient's authorized representative, must be willing and capable of giving written Informed Consent and must be able to adhere to dosing and visit schedules as well as meet all study requirements

Inability to give voluntary informed consent

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization obtained from the subject/legal representative prior to performing any protocol-related procedures

Provide informed consent for genetic sampling and analyses

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

All participants will undergo standard written informed consent procedures as dictated by the City of Hope Human Research Protections Office prior to performing any screening procedures that are not part of standard-of-care; informed consent will be obtained by the principal investigator, collaborating investigators, or other Institutional Review Board (IRB) designated personnel who will meet the training requirements established by the IRB; with the support of research personnel, he/she will explain the nature, duration, purpose of the study, potential risks, alternatives and potential benefits, and all other information contained in the informed consent document; in addition, they will review the experimental subject's bill of rights and the Health Insurance Portability and Accountability Act (HIPAA) research authorization form; prospective research participants will be informed that they may withdraw from the study at any time and for any reason without prejudice; prospective research participants will be afforded sufficient time to consider whether or not to participate in the research

CELL PROCUREMENT: Written informed consent for procurement signed by subject or legal guardian of a pediatric subject and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information

LYMPHODEPLETION: Written informed consent for the main study signed by subject or legal guardian of a pediatric subject

Voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Documented informed consent of the participant and/or legally authorized representative

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Documented informed consent of the subject and/or legally authorized representative

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Ability to understand and the willingness to sign a written informed consent that is consistent with International Conference on Harmonization (ICH)-Good Clinical Practice (GCP) guidelines

Voluntary written informed consent

Subject or subject's legally acceptable representative has provided informed consent.

Written informed consent obtained prior to biopsies and blood samples

Written informed consent obtained prior to biopsies and blood samples

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Patients must understand and sign informed consent that explains the neoplastic nature of their disease, the procedures to be followed, the experimental nature of the treatment, alternative treatments, potential risks and toxicities, and the voluntary nature of participation

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care. Participants should consent and enter the study within a maximum of 8 weeks of their last dose of ixazomib in the parent study or as agreed by the Millennium clinician/designee.

Willingness to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information, and the ability to comply with the study requirements (note: HIPAA authorization will be included in the informed consent)

Provision of written informed consent to participate in this investigational study

Subjects must have the ability to understand and the willingness to sign a written informed consent document and Health Insurance Portability and Accountability Act (HIPAA) consent document; voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Written informed consent must be obtained prior to enrolling in the rollover study and receiving the study treatment. If consent cannot be expressed in writing, then the consent must be formally documented and witnessed, ideally via an independent trusted witness

Must be capable of providing informed consent

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate will be obtained according to institutional guidelines

Inability to give informed consent

Patients who give a written informed consent obtained according to local guidelines

Diagnostic or laboratory studies performed exclusively to determine eligibility for this trial must only be done after obtaining written informed consent from all patients, which can be accomplished using the study specific informed consent or another consent, such as the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) screening protocol; studies or procedures that were performed for clinical indications (not exclusively to determine eligibility) may be used for screening or baseline values even if the studies were done before informed consent was obtained, if the patient agrees

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Patient and/or legal guardian must sign informed consent for BMT

The patient must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts

All patients must have provided informed consent for correlative studies

Written informed consent obtained prior to any study-related procedure being performed.

Signed written informed consent including Health Insurance Portability and Accountability Act (HIPAA) according to institutional guidelines

Legal guardians must sign an informed consent indicating that they are aware of this study, the possible benefits, and toxic side effects; legal guardians will be given a signed copy of the consent form

Inability or unwillingness of research participant or legal guardian/representative to give written informed consent

Patients must give documented informed consent to participate in this study

Subject/parental/guardian permission (informed consent), and child assent for subjects >= 7 years

PART 2 GROUP 1 INCLUSION CRITERIA: All subjects or a parent/guardian must sign written informed consent

PART 2 GROUP 2A INCLUSION CRITERIA: All subjects or a parent/guardian must sign written informed consent

PART 2 GROUP 3 INCLUSION CRITERIA: All subjects or a parent/guardian must sign written informed consent

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Patients or parents/legal guardian must be able to give informed consent

mCRPC EXPANSION COHORT: Patient must be capable of understanding and complying with protocol requirements and is willing to give informed consent

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information\r\n* NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Written informed consent

Written informed consent for transplant

Unable to give informed consent

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All subjects must have the ability to understand and the willingness to sign a written informed consent; they are to give voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Any psychiatric disorder that prohibits obtaining informed consent

Informed consent

Patients or their legally authorized representative must have the ability to understand and provide signed informed written consent

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

The subject must be deemed competent to give informed consent

The subject is cognitively impaired, and unable to give informed consent

ability to consent

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Patient must willingly provide written consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side effects, risks, and discomforts.

PRIOR TO CELL PROCUREMENT: Informed consent explained to, understood by and signed by the patient or legal guardian for pediatric patients; patient and/or legal guardian given a copy of informed consent form for procurement

PRIOR TO LYMPHODEPLETION: Informed consent explained to, understood by and signed by the patient or legal guardian for pediatric patients; patient and/or legal guardian given a copy of informed consent form

Patients must sign an informed consent indicating they are aware of the investigational nature of this study, in keeping with the policies of the hospital

Capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent

Has given written consent to participate in the study.

Voluntary written consent before any research related procedures or therapy

Patients must have signed an approved informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Subject has given voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to their future medical care

Patients must sign an informed consent form indicating that they are aware of the investigational nature of this study, in keeping with the policies of the hospital

Voluntary written consent

Patients unable to comprehend and give informed consent are excluded

Ability for patient (and if applicable parent or legal guardian) to understand and the willingness to sign a written informed consent document, or for a parent or legal guardian to give assent for those cases where a very young patient is unable to understand or sign the consent

Gives voluntary informed consent

Subject is capable of understanding the informed consent process

Written informed consent is given

All participants and/or their parents or legally authorized representatives must sign a written informed consent; assent will be obtained for all participants under the age of 18 years

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Ability to give informed consent

The subject has been fully informed about the study and has signed the informed consent form and, where appropriate, Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information\r\n* NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Patient has given written informed consent.

Unwilling or inability to give informed consent

Inability to obtain informed consent from patient or surrogate

Patients must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the nature of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts

Informed consent

Written and voluntary informed consent

Patients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved

Must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks and discomforts

Have signed an informed consent indicating that the patient is aware of the neoplastic nature of their disease and have been informed of the procedures of the protocol, the experimental nature of the therapy, possible alternative therapies, potential benefits, side effects, risks, and discomforts

Written informed consent

Written informed consent from patient or legal representative

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information prior to registration; NOTE: HIPAA authorization may be included in the informed consent or obtained separately; subject must have the ability to understand and willingness to sign the written informed consent document

Sign Subject Information Sheet and Informed Consent Form

Capable of understanding and complying with the protocol requirements and has signed the informed consent document; voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Encephalitis, meningitis, or uncontrolled seizures in the year prior to informed consent

Patient, or the patient’s legal representative, has voluntarily agreed to participate by giving written informed consent

DONOR: Written informed consent

Patients must have the ability to give informed consent

Patients must be informed of the investigational nature of this study and given written informed consent in accordance with institutional and federal guidelines

All patients must be informed of the investigational nature of this study and have given written consent in accordance with institutional and federal guidelines; patient must sign an informed consent document indicating that they understand the purpose of and procedures required for the study, and are willing to participate in and comply with the guidelines of the study

Inability to understand or give an informed consent

All patients must be informed of the investigational nature of this study and must provide written informed consent in accordance with institutional and federal guidelines; a copy of the informed consent document signed by the patient must be given to the patient

Cognitive impairment that precludes a patient from acting as his or her own agent to provide informed consent

Subjects unable to give informed consent

Subject has provided informed consent

Have the ability to understand, and have given written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients must be informed of the investigational nature of this study and must sign and\\ give written informed consent in accordance with institutional and federal guidelines

Written and signed informed consent from the parent(s) or legal representative (guardian) and assent from the minor participant. Written informed consent from subjects ?18 years.

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Ability to give written informed consent

Patient understands the nature of the procedure, is willing to comply with associated follow–up evaluations, and provide written informed consent prior to the procedure

Age ? 18 years with the capacity to give written informed consent

Patients must have signed informed consent indicating that they are aware of the investigational nature of the study, and are aware that participation is voluntary

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent will be obtained, when appropriate, according to institutional guidelines

All subjects and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Ability to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

A written informed consent MUST be obtained from the patients and/or their parents/legal guardians prior to enrollment indicating their awareness of investigational nature of this study

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Ability to give informed consent

Subjects must be willing and able to provide written informed consent for the trial and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of protected health information\r\n* NOTE: HIPPA authorization may be included in the informed consent or obtained separately

Voluntary written consent with appropriate parent/guardian consent and minor information sheet for participants < 18 years of age

Unable to give informed consent

Has any mental or medical condition that prevents the patient from giving informed consent

All patients and/or their parents or legally authorized representatives must sign a written informed consent.

Ability to consent to treatment - patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Any perceived inability to directly provide informed consent (note: consent may not be obtained by means of a legal guardian)

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

All patients must be informed of the investigational nature of this study and given written informed consent in accordance with institutional and federal guidelines

Patients must give informed consent

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Subjects must give written informed consent to participate in this trial

Patient and/or parents or authorized legal representative have signed a written informed consent/assent per institutional guidelines

Patient must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patient consent must be appropriately obtained in accordance with applicable local and regulatory requirements. Each patient must sign a consent form prior to enrollment in the trial to document their willingness to participate

Capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form

Written informed consent in accordance with federal, local, and institutional guidelines

Written informed consent obtained

All patients must be informed of the investigational nature of this study and have given written consent in accordance with institutional and federal guidelines

Ability to understand and the willingness to sign a written informed consent document and consent to the serial nature of the proposed Personalized ANtibodies for Gastro-Esophageal Adenocarcinoma (PANGEA) treatment with first, second and third line therapy as tolerated

Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution; patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy

Patients must sign an informed consent document that indicates they are aware of the investigational nature of the treatment in this protocol as well as the potential risks and benefits

Provision of written informed consent

Consent: all patients must be informed of the investigational nature of this study and given written informed consent in accordance with institutional and federal guidelines

All patients must be informed of the investigational nature of this study and must be given written informed consent in accordance with institutional and federal guidelines

Patients must sign an informed consent document that indicates they are aware of the investigational nature of the treatment in this protocol as well as the potential risks and benefits

All research participants must have the ability to understand and willingness to sign a written informed consent or age appropriate assent for pediatric patients\r\n* Note: For research participants who do not speak English, a short form consent may be used with a City of Hope (COH) certified interpreter/translator to proceed with screening and leukapheresis, while the request for a translated full consent is processed; however, the research participant is allowed to proceed with lymphodepletion and T cell infusion only after the translated full consent form is signed

All subjects must have the ability to understand and the willingness to sign a written informed consent\r\n* Note: For research participants who do not speak English, a short form consent may be used with a COH certified interpreter/translator to proceed with screening and leukapheresis, while the request for a translated full consent is processed; however, the research participant is allowed to proceed with lymphodepletion and T cell infusion only after the translated full consent form is signed

All research participants must have the ability to understand and the willingness to sign a written informed consent\r\n* Note: For research participants who do not speak English, a short form consent may be used with a COH certified interpreter/translator to proceed with screening and leukapheresis, while the request for a translated full consent in processed; however, the research participant is allowed to proceed with lymphodepletion and T cell infusion only after the translated full consent form is signed

Voluntary written consent signed before performance of any study-related procedure not part of normal medical care

Informed Consent: All subjects and/or legal guardians must sign informed written consent. Assent, when appropriate, will be obtained according to institutional guidelines.

Inability to give informed consent or lacks decision making capacity

Capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent

Willing to sign an informed consent form, indicating awareness of the investigational nature of this study that is in keeping with the policies of the institution.

Written voluntary informed consent

Patient has voluntarily agreed to participate by giving written informed consent/assent for the trial

Patients must have the ability to give informed consent

Participant has the ability and the willingness to sign the informed consent document (for adults only, for participants with mild cognitive abilities may use a legally authorized representative)

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that the subject may withdraw consent at any time without prejudice to future medical care

Patient or patient’s legal representative, parent(s) or guardian should provide written informed consent; assent of a minor if participant’s age is at least seven and less than eighteen years

Able to comprehend and provide written informed consent in accordance with institutional and federal guidelines

Must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks and discomforts

Patients must have the ability to understand the study, its risks, side effects, potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).

The recipient and/or the recipient's legal guardian must have been informed of the investigational nature of this study and have signed a consent form which is in accordance with Federal guidelines

Capable of providing informed consent

Ability to comprehend and willing to sign an informed consent, assent obtained from minors

Patients must be aware of the investigational nature of the therapy and provide written informed consent

Written informed consent is given

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study

Patient capable of giving informed consent

Written informed consent in accordance with federal, local, and institutional guidelines

Written informed consent in accordance with federal, local, and institutional guidelines

Written voluntary informed consent

Clinical performance status of ECOG 0-2 within 30 days of signing informed consent (Turnstile II)

All patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines.

Patient capable of giving informed consent

Patient or patient’s legal representative, parent(s) or guardian should provide written informed consent; assent of a minor if participant’s age is at least seven and less than eighteen years

RECIPIENT: Ability of subject or legally authorized representative (LAR) (if the patient is deemed by the treating physician to be cognitively impaired or questionably impaired in such a way that the ability of the patient to give informed consent is questionable) to understand and the willingness to sign a written informed consent document indicating that they are aware of the investigational nature of this study or written informed consent obtained from parent or legal guardian if subject is a minor

Written, informed consent according to institutional guidelines

Subjects given written informed consent

Patients or legal guardians must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects; patients or their guardians will be given a copy of the consent form

Voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Capable of informed consent

Written informed consent obtained prior to enrolling in roll-over study and receiving study medication • If consent cannot be expressed in writing, it must be formally documented and witnessed, ideally via an independent trusted witness

Legal guardians must sign an informed consent indicating that they are aware of this study, the possible benefits, and toxic side effects; legal guardians will be given a signed copy of the consent form; note: for inclusion on biology studies after enucleation, the patient or his/her legal guardian, as appropriate, must provide written informed consent for SJRET6 protocol within 60 days of the removal of the tissue (eye) sample

Inability or unwillingness of research participant or legal guardian/representative to give written informed consent

Written informed consent in accordance with federal, local, and institutional guidelines

All patients must be informed of the investigational nature of this study and have given written consent in accordance with institutional and federal guidelines

Ability to give informed consent

Patient has voluntarily agreed to participate by giving written informed consent

Patients must be aware of the investigational nature of the therapy and provide written informed consent

Patients must be able to give informed consent; parent or legal representative will be asked to consent for patients younger than 18 year old

Patients must give documented informed consent to participate in this study

Patients must sign an informed consent indicating that they are aware of the investigational nature of the study in keeping with the policy of MD Anderson Cancer Center (MDACC)

All patients must be informed of the investigational nature of this study and given written informed consent in accordance with institutional and federal guidelines

Patient should be able to provide signed written informed consent; before any study procedures are performed, subjects will have the details of the study described to them, and they will be given a written informed consent document to read; then, if subjects consent to participate in the study, they will indicate that consent by signing and dating the informed consent document in the presence of study personnel; written consent will include a Health Insurance Portability and Accountability Act (HIPAA) form according to institutional guidelines

There will be no upper age limit for eligibility; elderly patients will be eligible for participation provided they are competent to provide informed consent, or written consent can be provided by their duly appointed healthcare proxy

Patients must voluntarily sign an informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of the hospital

Patients unable to give informed consent for the study will be excluded

Capability of providing informed consent

Inability to grant informed consent

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must have signed an authorization for the release of their protected health information at all sites except the National Institutes of Health (NIH)

Inability to understand or give an informed consent

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information; Note: HIPAA authorization may be included in the informed consent or obtained separately

Have mental deficits and/or psychiatric history that may compromise the ability to give written informed consent or to comply with the study protocol.

All patients must have a surgical and medical oncology consult prior to signing informed consent

Inability to obtain informed consent

Ability to understand and the willingness to sign a written informed consent document; the patient must be aware that his/her disease is neoplastic in nature and willingly consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts

Provision of written informed consent

Written voluntary informed consent

Psychiatric disorder that would preclude patients from signing an informed consent

All patients and/or their parents or legal guardians must sign a written informed consent

Subjects given written informed consent

Patients or legal guardians must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects; patients or their guardians will be given a copy of the consent form

Able to comprehend and provide written informed consent in accordance with institutional and federal guidelines.

Patients, parents/guardian(s), legally authorized representatives (LAR), or durable power of attorney must be able to give consent and sign the informed consent document; pediatric subjects will be included in age appropriate discussion and verbal assent will be obtained for those > 12 years of age, when appropriate

Recipient must have signed a voluntary, informed consent in accordance with institutional and federal guidelines

Informed consent

Have provided informed consent

Ability to give informed consent

Written voluntary informed consent

Must have the capacity to give informed consent

Written informed consent by patients and/or their parents or legal guardians; assent for those patients inclusive of ages 12 to 17

Patients with psychiatric or addictive disorders that would preclude obtaining informed consent

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Inability to give informed consent or assent

Patients must be capable of informed consent

The patient and/or the patient's legally authorized guardian must acknowledge in writing that consent to become a study subject has been obtained in accordance with the institutional policies approved by the United States (U.S.) Department of Health and Human Services; informed consent must be signed prior to registration on study

Recipients will sign informed consent approved by the Committee on the Use of Human Subjects at the University of Minnesota

Able to comprehend and provide written informed consent in accordance with institutional and federal guidelines

Able to comprehend and provide written informed consent in accordance with institutional and federal guidelines

Psychological condition that renders the patient unable to understand the informed consent

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care

Subjects must sign a written informed consent in accordance with institutional guidelines

Patients must demonstrate the ability and willingness to give informed consent.

Subject (or legal guardian) must sign a written informed consent in accordance with institutional guidelines

Informed consent must be obtained

Ability to give informed consent

Signed informed consent form by patients and/or patients' parents/legal guardians and age appropriate assent form by the patients obtained before any study specific procedure

Subject must be >=18 years of at the time of signing the informed consent.

Informed consent: All participants and/or their parents or legally authorized representatives must sign a written informed consent. Assent, when appropriate, will be obtained according to institutional guidelines. Participants must be willing to comply with all aspects of the protocol.

Informed Consent

Written informed consent obtained prior to any study-related procedure being performed;

Voluntary written consent (adult or legally authorized representative; or parental/guardian)

Patient consent must be appropriately obtained in accordance with applicable local and regulatory requirements. Each patient must sign a consent form prior to enrollment in the trial to document their willingness to participate.

Written informed consent for the trial

Following receipt of verbal and written information about the trial, patients must provide signed informed consent before any trial-related activity is carried out.

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information\r\n* NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Provision of informed consent prior

Patients must give informed consent

Voluntary written informed consent and HIPAA authorization and agree to comply with all protocol-specified procedures and follow-up evaluations

Capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form

Subject is ? 18 years of age at the time of signing the informed consent form (ICF)

Written informed consent prior to admission to this study

Written informed consent obtained prior to enrolling in the roll-over study and receiving study medication. If consent cannot be expressed in writing, it must be formally documented and witnessed via an independent trusted witness.

Patients must consent to be in the study and sign an approved consent form conforming with institutional guidelines

Written informed consent in accordance with federal, local, and institutional guidelines

Written informed consent that is consistent with International Conference on Harmonisation Tripartite Guideline on Good Clinical Practice guidelines

Patients must give written informed consent prior to registration on the study

Inability to give informed consent

Patients must sign informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of the hospital.

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information; note: HIPAA authorization may be included in the informed consent or obtained separately

Informed consent

Cognitive impairment such as to preclude informed consent

Patients must be capable of understanding of the nature of their disease and willingly give consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side effects, risks, and discomforts

Patients, or legal guardians, and donors must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects

Written informed consent

Written informed consent

Unwillingness or inability to given written informed consent.

Cases involving subjects who are minors, pregnant or require an authorized representative for informed consent

Subjects who are ?18 years of age on the date of written informed consent.

Subjects who have voluntarily agreed to participate by giving written informed consent.

All patients and/or their parents or legal guardians must sign a written informed consent

102 Age ? 18 at the time of informed consent.

Written informed consent and authorization for release of personal health information obtained according to local laws.

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information\r\n* NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Adults capable of giving informed consent.

Documented informed consent of the participant and/or the legally authorized representative

Encephalitis, meningitis, or uncontrolled seizures in the year prior to informed consent

Ability to understand and the willingness to sign a written protocol specific informed consent for tissue harvest or a parental/guardian informed consent and pediatric assent when appropriate.

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Voluntary written consent

Written informed consent obtained to participate in the study and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information

Written informed consent in accordance with institutional guidelines.

Patient is capable of giving informed consent

Voluntary written consent

Documented informed consent of the participant and/or legally authorized representative

Voluntary written consent (adult or parental/guardian)

DONORS: Voluntary written consent prior to the performance of any research related procedure

All patients must be informed of the investigational nature of this study and have given written consent in accordance with institutional and federal guidelines

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Written informed consent

Ability to consent

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information prior to registration for protocol therapy\r\n* NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Ability to give informed consent and comply with the protocol

Each patient must be aware of the nature of their disease and must willingly consent to treatment after being informed of alternatives, potential benefits, side effects, and risks

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Written informed consent according to institutional guidelines, and

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care.

Written informed consent provided

Willing and able to provide written informed consent and Health Insurance Portability and Accountability Act of 1996 (HIPAA) authorization for the release of personal health information \r\n* NOTE: HIPAA authorization may be either included in the informed consent or obtained separately

Participant has given voluntary signed written informed consent before performance of any study-related procedure that is not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to their future medical care

Subjects or their legal guardian must sign a written informed consent in accordance with institutional guidelines

The subject must be deemed competent to give informed consent

The subject is unable to give informed consent

The subject is cognitively impaired, and unable to give informed consent

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information

All patients or their parents or legal guardians must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legal guardians must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

All patients and/or their parents or legal guardians must sign a written informed consent

Patient has given voluntary written informed consent before performance of any study-related procedures not part of standard (non-investigational) medical care

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information prior to registration. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.

Informed consent and assent obtained as appropriate

All patients and/or their parents or legal guardians must sign a written informed consent

History of HIV-associated encephalopathy; dementia of any kind; seizures in the past 12 months; any perceived inability to directly provide informed consent (Note: Consent may not be obtained by means of a legal guardian)

Patients must give informed consent

Voluntary written consent

Inability to give voluntary informed consent or obtain a parent or guardian’s informed consent

Informed consent

All patients must be informed of the investigational nature of this study and must give written informed consent in accordance with institutional and federal guidelines

All patients and/or their parents or legal guardians must sign a written informed consent

Written informed consent and Health Insurance Portability and Accountability Act (HIPPA) authorization for release of personal health information

Patients must sign an informed consent document that indicates they are aware of the investigative nature of the treatment in this protocol as well as the potential risks and benefits

The participant (or legally acceptable representative if applicable) provides written informed consent for the trial

Patient (or his or her legally accepted representative) has provided written informed consent to participate in the study

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Signed informed consent to participate in the study, including participation in the expansion cohort after safety of enzalutamide and gemcitabine and cisplatin have been established, must be obtained from patients after they have been fully informed of the nature and potential risks by the investigator (or his/her designee) with the aid of written information

All patients and/or their parents or legal guardians must sign a written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent

Not willing to follow protocol requirements or to give informed consent

Ability to give written informed consent

Any history of HIV-1 associated encephalopathy; dementia of any kind; seizures in the past 12 months; any perceived inability to directly provide informed consent (note: consent may not be obtained by means of a legal guardian)

All patients and/or their parents or legal guardians must sign a written informed consent

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Signed, written informed consent in accordance with federal, local, and institutional guidelines

All patients and/or their parents or legal guardians must sign a written informed consent

Written informed consent in accordance with federal, local, and institutional guidelines

Any perceived inability to directly provide informed consent (note: consent may not be obtained by means of a legal guardian)

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines; patients must be willing to comply with all aspects of the protocol

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Written informed consent in accordance with federal, local, and institutional guidelines

Untreated psychiatric conditions preventing informed consent

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Voluntary written informed consent

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Capable of giving written informed consent

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Able to give informed consent (if > 18 years), or with a legal guardian capable of giving informed consent (if < 18 years)

Unable to give informed consent (if > 18 years) or with a legal guardian (if < 18 years) unable to give informed consent

DONOR: Donors able to give informed consent (if > 18 years), or with a legal guardian capable of giving informed consent (if < 18 years)

DONOR: Persons unable to give informed consent (if > 18 years) or with a legal guardian (if < 18 years) unable to give informed consent

Voluntary written consent

Informed consent and assent (as applicable) obtained from parent/guardian and child

Signed written informed consent; patient must be capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent

Patients unable to comprehend and give informed consent are excluded

Ability to understand and willingness to provide informed consent, and the willingness to comply with the requirements of the protocol; informed consent may be obtained with the assistance of a medical translator according to institutional policies

Inability to understand or give an informed consent

Patients unable to comprehend and give informed consent are excluded

Subjects must be willing to give written informed consent per institutional guidelines and must be able to adhere to dose and visit schedules

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Ability to give informed consent; for subjects < 18 years old their legal guardian must give informed consent; pediatric subjects will be included in age appropriate discussion and verbal assent will be obtained for those >= 12 years of age, when appropriate

Voluntary written consent

Inability to understand the investigational nature of the study to provide informed consent

Ability and willingness to participate in the informed consent process and including signing a copy of the informed consent form

Patient’s written informed consent

Must sign informed consent, witnessed, and dated prior to entry

Ability to give informed consent; for patients < 18 years of age their legal guardian must give informed consent; pediatric patients will be included in age-appropriate discussion in order to obtain verbal assent\r\n* Durable power of attorney form completed (patients >= 18 years of age only)\r\n* Female patients (and when relevant their male partners) must be willing to practice birth control (including abstinence) during and for two months after treatment, if of childbearing potential

Patients must be informed of the investigational nature of the study, and must sign an informed consent in accordance with the institutional rules

Inability to obtain informed consent because of psychiatric or complicating medical problems

Subject must have read, understood, and provided written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization after the nature of the study has been fully explained

Subject must have read, understood, and provided written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization after the nature of the study has been fully explained

Ability to give voluntary informed consent and to comply with treatment and required tests

All patients and/or their parents or legal guardians must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Ability to give written informed consent and willingness to comply with the requirements of the protocol

Patients must give documented informed consent to participate in this study

Inability to understand or give an informed consent

Patients must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional standards and federal guidelines

Patients must be informed of the investigative nature of the treatment, must give appropriate informed consent to protocol procedures and must sign an Informed Consent documentation form

Patients or legal guardians must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects; patients or their guardians will be given a copy of the consent form

Informed consent must be obtained from all subjects prior to beginning therapy

All participating patients must exercise informed voluntary consent and sign a consent form approved by the University of Minnesota Committee on the Use of Human Subjects in Research

Ability to understand and the willingness to sign a written informed consent document; voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care

Inability to give informed written consent

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Unable to give informed consent

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines; for all patients the appropriate consent form for this registration is the Step 2 Consent

Inability to give informed written consent

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines\r\n* Voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Aged ?18 years at signing of informed consent.

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent prior to any study-related procedures in accordance with institutional and federal guidelines

Male or female is 1 to ? 18 years of age at the time of signing the Informed Consent Form / Informed Assent Form (ICF/IAF).

Venous thromboembolism within 6 months prior to signing Informed Consent Form.

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Lack of parents'/guardian's informed consent for children who are minors.

Patients must be able to provide voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Written informed consent

Written informed consent and/or assent from patient, parent or guardian.

Patients must be informed of the investigational nature of this study and must sign and give written informed consent for this protocol in accordance with institutional and federal guidelines

Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.

REGULATORY CRITERIA: Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Subject is male or female, ? 18 years old at the time of signing the informed consent form (ICF).

Aged ?18 years at signing of informed consent

Written informed consent

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Participant must be capable of understanding and complying with the protocol and willing to sign a written informed consent document

Patients must have the ability to understand and sign an approved informed consent and authorization permitting release of personal health information

All patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Subject is ? 18 years of age at the time of signing the informed consent form (ICF)

Voluntary agreement to provide written informed consent and the willingness and ability to comply with all aspects of the protocol.

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Able and willing to give voluntary, written and signed informed consent before any screening procedure and according to local guidelines

Ability to read and understand the informed consent form and willingness and ability to give informed consent and demonstrate comprehension of the trial before undergoing any trial activities

Mentally incompetent or unable or not willing to give written informed consent or meet study requirements

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Written Informed Consent

Subject is considered an adult according to local regulation at the time of signing informed consent.

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form. If the subject is less than 18 years old, an Assent form and parental/guardian Consent form (replacing \you will\ with \your child will\ will be required).

All patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Matched Related Donor: Capable of giving written, informed consent

Age ? 18 at time of informed consent

Patients must sign a written informed consent prior to entering the study.

Written informed consent for the transplant phase

Subject has voluntarily agreed to participate by giving written informed consent

Signed written informed consent must be obtained and documented according to International Conference on Harmonisation (ICH) and local regulatory requirements

have undergone ASCT within the period ? 3 months prior to signing the informed consent form.

Subjects must be ?18 years of age at the time of signing the Informed Consent Form (ICF);

Written informed consent to participate in this study before the performance of any study-related procedure

Written informed consent

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Written, informed consent and assent following guidelines of the Institutional Review Board, National Cancer Institute (NCI), Food and Drug Administration (FDA), and Office of Human Research Protections (OHRP)

Inability or unwillingness of research participant or legal guardian/representative to give written informed consent

All patients must be informed of the investigative nature of the clinical trial and give written informed consent in accordance with institutional and federal guidelines

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients and/or their parents or legal guardians must sign a written informed consent

Subject must have read, understood, and provided written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization after the nature of the study has been fully explained; and

Voluntary written consent given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Informed Consent Signed informed consent according to institutional guidelines must be obtained. Assent, when appropriate, will be obtained according to institutional guidelines.

All subjects or their legally authorized representative must be informed of the investigational nature of the study and provide written informed consent and HIPAA authorization for release of personal health information before performance of any study related procedure not part of routine medical care. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.

Signed written informed consent must be obtained and documented according to International Conference on Harmonisation (ICH) and local regulatory requirements

Patient is an adult male/female ? 18 years old at the time of informed consent and has signed informed consent before any trial related activities and according to local guidelines. Female patients must be postmenopausal.

Patient must give written informed consent

Subjects who have voluntarily signed a written informed consent in accordance with institutional policies after its contents have been fully explained to them

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Written informed consent is given

Obtained written informed consent

Written informed consent must be obtained before any assessment is performed.

Able to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines; for all patients, the appropriate consent form for this registration is the Step 2 Consent Form

Diagnosis of psychiatric or addictive disorders that would preclude obtaining informed consent

Written informed consent to participate in this study

Subjects who have voluntarily signed a written informed consent in accordance with institutional policies after its contents have been fully explained to them

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Provided written consent

Inability to understand or give an informed consent

Signed informed consent indicating that patients are aware of the investigational nature of this study in keeping with the policies of University of Texas M.D. Anderson Cancer Center (UTMDACC)

Patient must give written informed consent

Ability to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Patient must be capable of understanding and complying with protocol requirements and is willing to give informed consent

Informed consent

Patients or legal guardians must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects; patients or their guardians will be given a copy of the consent form

Written informed consent and HIPAA authorization for release of personal health information.

All patients and/or their parents or legal guardians must sign a written informed consent

All patients and/or their legal guardians must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Documented informed consent

Written informed consent prior to any procedure

Autologous HCT < 3 months prior to the time of signing the informed consent form

MDS subjects may not receive RIC and must be < 50 years of age at the time of signing the informed consent form

Ability to provide written informed consent in accordance with federal, local, and institutional guidelines

Subject is considered an adult according to local regulation at the time of obtaining informed consent.

Men and women ? 18 years of age, at the time of signing the informed consent form (ICF).

They or their legal guardian must give their informed consent

Written, informed consent and assent following Institutional Review Board, National Cancer Institute (NCI), Food and Drug Administration (FDA), and Office for Human Research Protections (OHRP) Guidelines

Inability or unwillingness of research participant or legal guardian/representative to give written informed consent

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Ability to understand and willingness to sign a written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Capable of giving informed consent

Signed and dated written informed consent prior to admission to the study in accordance with international conference on harmonization (ICH)-good clinical practice (GCP) guidelines and to the local legislation

Subject or an authorized legal representative is willing and able to give prior written informed consent for investigation participation;

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Patients must understand and willingly sign an approved informed consent, and authorization permitting release of personal health information

Ability to give informed consent

Written informed consent provided

Signed informed consent to participate in the study must be obtained from patients after they have been fully informed of the nature and potential risks by the investigator (or his/her designee) with the aid of written information

All patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Written informed consent and authorization obtained from the subject/Health Insurance Portability and Accountability Act (HIPAA)-appointed legal representative prior to performing any protocol-related procedures including screening evaluations

Patients must be willing to give written informed consent, and sign an institutionally approved consent form before performance of any study-related procedure not part of normal medical care as noted above; with the exception of 1 cycle of chemotherapy based on current diagnosis and clinical condition, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Subject is ? 18 years of age or is considered an adult according to local regulation at the time of signing informed consent.

Capable of giving written informed consent, which includes compliance with the requirements and restrictions

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Signed, written informed consent in accordance with federal, local, and institutional guidelines

All patients and/or their parents or legal guardians must sign a written informed consent

Voluntary written informed consent must be given before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care.

Has any mental or medical condition that prevents the subject from giving informed consent or participating in the trial

Give informed consent

Refuses to give informed consent

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that the patient may withdraw consent at any time without prejudice to future medical care

Patients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved

Be willing and able to provide written informed consent for the trial and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.

Subject has given voluntary signed written informed consent before performance of any study-related procedure that is not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to their future medical care

Any mental or medical condition that prevents the subject from giving informed consent or participating in the trial.

Written informed consent and HIPAA authorization for release of personal health information

Patient and his/her partner agree to use adequate contraception after providing written informed consent through 3 months after the last dose of PBI 05204, as follows:

Written informed consent obtained from the patient/legal representative;

All patients >= 18 years must sign a written informed consent; patients < 18 years old must provide assent, and the parent or legal guardian must sign the written informed consent

Unable to give informed consent

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Patient will read, understand and sign the informed consent and Health Insurance Portability and Accountability Act (HIPAA) agreement

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent prior to any screening procedures in accordance with institutional and federal guidelines

Subjects must give written informed consent to participate in this trial

Written informed consent must be obtained

Written informed consent

Written informed consent obtained from the patient/legal representative

Able to provide informed consent and have signed an approved consent form that conforms to federal and institutional guidelines to ensure compliance with Health Insurance Portability and Accountability Act (HIPAA) regulations

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Written informed consent in accordance with federal, local, and institutional guidelines

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Written informed consent in accordance with federal, local, and institutional guidelines

The patient must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts

Patients must understand and sign informed consent that explains the neoplastic nature of their disease, the procedures to be followed, the experimental nature of the treatment, alternative treatments, potential risks and toxicities, and the voluntary nature of participation

Informed consent must be signed prior to the treatment; patients must willingly consent after being informed of the procedure to be followed, the nature of the therapy, alternatives, potential benefits, side effects, risks and\r\ndiscomforts; (human protection committee approval of this protocol and a consent form is required)

Ability to understand the nature of this study and give written informed consent.

Written informed consent in accordance with federal, local, and institutional guidelines

Voluntary written informed consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Written informed consent in accordance with federal, local, and institutional guidelines

Inability to give informed consent

Written informed consent, Release of Medical Records Form and HIPAA reviewed and signed by patient or legally authorized representatives

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Patients must have the ability to understand the study, its risks, side effects, potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).

Written informed consent in accordance with federal, local, and institutional guidelines

Ability to understand and voluntarily give informed consent

All patients and/or a legal guardian must sign institutionally approved written informed consent document

Written informed consent

? 18 years at time of consent.

Psychiatric disorder that would preclude patients from signing an informed consent

Ability to understand and the willingness to sign a written informed consent document; voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care

The patient must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts

Written, voluntary informed consent.

Willing and able to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information\r\n* NOTE: HIPAA authorization may be either included in the informed consent or obtained separately

Written informed consent and HIPAA authorization for release of personal health information. HIPAA authorization may be included in the informed consent or may be obtained separately. NOTE: Central pathology review may be conducted any time after definitive surgery. Consenting participants may be pre-registered to the study and proceed with central pathology review before full eligibility has been confirmed. However ALL of the eligibility criteria must be met and formal study registration completed prior to submission of the sample for sequencing.

Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.

Written informed consent.

Inability or unwillingness of research participant or legal guardian/representative to give written informed consent

Written informed consent in accordance with federal, local, and institutional guidelines

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Inability or unwillingness of research participant or legal guardian/representative to give written informed consent

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Voluntary written consent

Written informed consent must be obtained from all patients before entry into the study

All patients must be informed and must sign and give written informed consent in accordance with institutional and federal guidelines; patients who are unable to comply with study and/or follow-up procedures are ineligible

Provide written informed consent (Screen 1 and Screen 2)

Voluntary written consent

Patients must have the ability to understand the study, its inherent risks, side effects and potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).

Written informed consent

Signed written informed consent including Health Insurance Portability and Accountability Act (HIPAA) according to institutional guidelines

Written informed consent in accordance with federal, local, and institutional guidelines

All patients and/or their parents or legal guardians must sign a written informed consent

Patients must have the ability to understand the study, its risks, side effects, potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Willing and able to provide written informed consent and authorization for use and release of health and research study information (Health Insurance Portability and Accountability Act [HIPAA] authorization)\r\n* NOTE: HIPAA authorization may be either included in the informed consent or obtained separately

Gives voluntary informed consent

Must be ? 18yrs at the time of signing informed consent.

Signed and dated written informed consent by start date of Screening visit in accordance with Good Clinical Practice (GCP) and local legislation.

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients must be informed of the investigational nature of this study and must sign and give written consent in accordance with institutional and federal guidelines

Voluntary written consent

Ability to understand and voluntarily give informed consent

Patient must be capable of understanding and complying with protocol requirements and is willing to give informed consent

Patients must give voluntary written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Patient (or parents/guardians, in the case of minors) must sign an informed consent document indicating that they are aware of the investigational nature of this study, which includes an authorization for the release of their protected health information

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Informed consent

All patients must sign a consent form indicating that they are aware of the investigational nature of the study; the informed consent form will indicate that the patient has been made aware of all other appropriate therapies

Patient should be able to provide signed written informed consent:\r\n* Before any study procedures are performed, subjects will have the details of the study described to them, and they will be given a written informed consent document to read; then, if subjects consent to participate in the study, they will indicate that consent by signing and dating the informed consent document in the presence of study personnel\r\n* Written consent will include a Health Insurance Portability and Accountability Act (HIPAA) form according to institutional guidelines

Signed written informed consent in accordance with federal, local, and institutional guidelines

Voluntary written consent

Ability and willing to give consent

? 18 years old at the time of informed consent.

Ability to give written informed consent and willingness to comply with the requirements of the protocol

Voluntary consent form

Written informed consent has been obtained

Voluntary written consent must have been given before performance of any study related procedure not part of standard medical care, with the understanding that consent may have been withdrawn by the participant at any time without prejudice to future medical care.

All patients and/or their parents or legal guardians must sign a written informed consent

Ability to give written informed consent and willingness to comply with the requirements of the protocol

Refusal or inability to give informed consent to participate in the trial

Ability to give written informed consent according to local guidelines

The patient must be willing and able to comply with all study protocol requirements. The patient or a legally authorized representative must fully understand all elements of the informed consent and have signed the informed consent according to institutional and federal regulatory requirements

Patients must have signed an approved informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Patient's Informed Consent. -

Written informed consent

Subject has no clinically significant co-morbidities (i.e. chronic illnesses existing simultaneously with and usually independent of breast cancer) that affect life expectancy. Subject has given written informed consent

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Able and willing to sign an informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent and Health Insurance Portability and Accountability Act (HIPAA) consent

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study.

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must be registered prior to treatment with study drug

Informed consent

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information

Written informed consent

Voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients must demonstrate the ability to understand the investigational nature of this study and must sign a written informed consent document in accordance with institutional and federal guidelines

Signed written informed consent and Health Insurance Portability and Accountability Act (HIPAA) consent

Written informed consent prior to registration on study

Voluntary written consent

Voluntary written consent

Inability to give informed consent

Ability to give informed consent; for recipients and donors < 18 years of age, their legal guardian must give informed consent; pediatric patients will be included in an age appropriate discussion in accordance with institutional guidelines

MATCHED RELATED DONOR: Age >= 2 and =< 60 years old and able to give consent or assent; for donors < 18 years old, the legal guardian must be able to provide informed consent and an evaluation by a licensed social worker (LSW) or psychiatric personnel will be needed to determine willingness to participate; pediatric patients will be included in an age appropriate discussion in accordance with institutional guidelines

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Written and voluntary informed consent

Patient must be capable of, and must voluntarily agree to participate by giving written informed consent

The patient must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts

Inability to understand or give an informed consent

Has given written Informed Consent

Signed informed consent to participate in the study must be obtained from patients after they have been fully informed of the nature and potential risks by the investigator (or his/her designee) with the aid of written information

Patients must give written informed consent

Voluntary agreement to provide written informed consent and the willingness and ability to comply with all aspects of the protocol

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Patients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved

Ability to understand and the willingness of the patient, parent or legal guardian to provide informed consent

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Voluntary written informed consent

Willing to provide voluntary written informed consent before performance of any study related procedure not part of normal medical care

Written, voluntary informed consent

Written informed consent in accordance with federal, local, and institutional guidelines; the patient must provide informed consent prior to the first screening procedure

Written informed consent

Patients must sign an informed consent form indicating that they are aware of the investigational nature of this study, in keeping with the policies of the hospital

All patients must be informed of the investigational nature of this study and must give written informed consent in accordance with institutional and federal guidelines

Voluntary written consent

Subjects must be willing to give written informed consent, and sign an institutionally approved consent form before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Psychiatric or addictive disorders that would preclude obtaining informed consent

Any medical condition, that would prevent the subject from signing the informed consent form.

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Signed Written Informed Consent\r\n* Before any study procedures are performed, subjects will have the details of the study described to them, and they will be given a written informed consent document to read; then, if subjects consent to participate in the study, they will indicate that consent by signing and dating the informed consent document in the presence of study personnel\r\n* Written consent will include a Health Insurance Portability and Accountability Act (HIPAA) form according to institutional guidelines

Written informed consent and assent as is age appropriate

Patient or parent/guardian capable of providing informed consent

Ability to understand the investigational nature of this study and to give informed consent

Written informed consent

Written informed consent according to institutional guidelines

All patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Inability to understand or give an informed consent

All patients must sign an IRB approved informed consent indicating their awareness of the investigational nature of this study. Patients must have signed an authorization for the release of their protected health information.

Ability to understand informed consent and signing of written informed consent document prior to initiation of protocol therapy

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care.

Patients must sign an informed consent indicating they are aware of the investigational nature of this study, in keeping with the policies of the hospital

Ability to give voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information\r\n*NOTE: HIPAA authorization may be included in the informed consent or obtained separately

Inability to give voluntary informed consent or guardian’s informed consent

Subjects must be able to understand and be willing to sign the written informed consent and Health Insurance Portability and Accountability Act of 1996 (HIPAA) authorization for release of personal health information. A signed informed consent form (ICF) must be appropriately obtained prior to the conduct of any trial-specific procedure. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.

Ability to give informed consent

Written, informed consent and assent following Institutional Review Board, National Cancer Institute (NCI), Food and Drug Administration (FDA) and Office for Human Research Protections (OHRP) guidelines

Inability or unwillingness or research participant or legal guardian/representative to give written informed consent

Written Informed Consent

Written informed consent must be provided.

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Ability to give informed consent

Patients and/or their parents or legal guardians must be capable of understanding the investigational nature, potential risks and benefits of the study. All patients and/or their parents or legal guardians must sign a written informed consent.

All subjects must have the ability to understand and the willingness to sign a written informed consent; they are to give voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Written informed consent/assent before any study-specific screening procedures. For pediatric patients, consent will be obtained from parent(s) or legal guardian(s) and the signature of at least 1 parent or guardian will be required. Investigators will also obtain assent of patients according to local, regional or national guidelines.

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Willing and able to provide written informed consent and HIPAA authorization for the release of personal health information. NOTE: HIPAA authorization may be either included in the informed consent or obtained separately.

Written informed consent in accordance with federal, local, and institutional guidelines

Able to give informed consent, or their legally authorized representative can give informed consent

Psychiatric disorder that would preclude patients from signing an informed consent

Any condition that may compromise the ability to give written informed consent or to comply with the study protocol.

Each patient must be aware of the nature of her disease process and must willingly consent to treatment after being informed of alternatives, potential benefits, side effects, and risks; eligibility testing that is considered standard of care may be done prior to informed consent but no immunotherapy related procedures or testing may occur without informed consent

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Competent to give informed consent

Study subjects must sign an approved informed consent and authorization permitting release of personal health information

Patients must have the ability to understand the study, its inherent risks, side effects and potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).

Psychiatric conditions/diseases that impair the ability to give informed consent or to adequately co-operate

Patients must give documented informed consent to participate in this study

Written informed consent

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Patients must be informed of the investigational nature of this study and sign written informed consent in accordance with institutional and federal guidelines

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Patients must sign an informed consent form approved for this purpose by the IRB of the University of Michigan Medical Center indicating that they are aware of the investigational aspects of the treatment and the potential risks

Must have provided informed consent for study participation.

Able and willing to sign an informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Ability to understand and willingness to sign a written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

Willing and able to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information; NOTE: HIPAA authorization may be either included in the informed consent or obtained separately

Ability to understand the nature of this study and give written informed consent.

Patients must give informed consent

Ability to understand the nature of this trial and give written informed consent

Subject (and/or parent/guardian for subject who otherwise is unable to provide independent consent, if acceptable to and approved by the site and/or site's IRB) must be willing to give written informed consent and be able to adhere to dose and visit schedules.

Ability to give informed consent

Signed informed consent that details the investigational nature of the study according to institutional and federal guidelines

Provision of written informed consent

Ability to give informed consent; for patients < 18 years of age their legal guardian must give informed consent; pediatric patients will be included in age-appropriate discussion in order to obtain verbal assent

Patient or patient’s legal representative, parent(s) or guardian able to provide written informed consent for the long-term follow-up gene therapy study 2006-0676

Written informed consent or assent

Voluntary, written informed consent.

Patients must have the ability to understand and voluntarily sign a written informed consent; if an unexpected non-English speaking patient or if an illiterate patient is encountered, current Institutional Review Board (IRB) guidelines on obtaining informed consent will be followed; a voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Has given written informed consent.

Patients must voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients must be informed of the investigational nature of this study and must give written informed consent in accordance with institutional and federal guidelines

Lack of ability or willingness to give informed consent

Voluntary written informed consent

Patients capable of providing written, informed consent

Written informed consent

Patient must understand and voluntarily sign an informed consent form, with the understanding that the patient may withdraw consent at any time without prejudice to future medical care

The subject must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the experimental nature of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of this hospital.

Subjects must give written informed consent to participate in this trial

Voluntary written consent

Able to provide voluntary written informed consent, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients, or their legal guardians, must sign a written informed consent in accordance with institutional guidelines

Written informed consent to participate in this study before the performance of any study-related procedure

Patient (or legal representative where appropriate) must be capable of providing written informed consent.

Patient is capable of giving informed consent.

Patient is an adult, female ? 18 years old at the time of informed consent

Written informed consent which is consistent with International Conference on Harmonization, Good Clinical Practice (ICH-GCP) guidelines and local legislation.

Written informed consent and HIPAA authorization for release of personal health information; NOTE: HIPAA authorization may be included in the informed consent or obtained separately

All patients and/or their parents or legal guardians must sign a written informed consent

Men and women ? 18-years-old on the day of signing informed consent.

Informed consent

Willingness to sign informed consent by patient or patient’s legal representative

Research participant or legal guardian/representative must be willing to give written informed consent

Willing and able to understand and provide written informed consent. For minors or those incapable of providing written informed consent (i.e., incapacitated), understood, written and informed consent must be provided by a parent or legal guardian or representative.

Patient or his or her legal representatives must give written informed consent and privacy authorization prior to participation in the study.

Written patient or parental (or appropriate legal representative) IRB approved informed consent as appropriate.

Ability to give written informed consent and willing to comply with the requirements of the protocol; and for Part 3, to give written informed consent for 2 cancer biopsy procedures

Patients must sign an informed consent indicating that they are aware of the investigational nature of the study

Inability to give an informed consent

Patients must have the ability to give informed consent

Patients must have the ability to give informed consent

Written informed consent in accordance with federal, local, and institutional guidelines

Unable to give informed consent

Inability or unwillingness or research participant or legal guardian/representative to give written informed consent

Research participant or legal guardian/representative is able and willing to give written informed consent

Patient must have the ability to give written informed consent

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Written informed consent that is consistent with ICH-GCP guidelines and local regulations

Written informed consent;

REGULATORY CRITERIA: Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Voluntary written consent must be given before performance of any study-related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the participant at any time without prejudice to future medical care.

Provision of written informed consent

patient had given written informed consent.

All patients and/or their parents or legal guardians must sign a written informed consent

Written informed consent obtained before undergoing any study-related activities

Has provided written informed consent prior to any study related activities.

Written informed consent and any locally required authorization (eg, Health Insurance Portability and Accountability Act [HIPAA] in the USA) obtained from the subject/legal representative prior to performing any protocol-related procedures, including screening evaluations

Subject has provided informed consent or subject's legally acceptable representative has provided informed consent when the subject has any kind of condition that, in the opinion of the Investigator, may compromise the ability of the subject to give written informed consent.

Has the subject given written informed consent?

Written informed consent provided.

The subject has read and understood the written informed consent form (ICF) and is willing and able to give informed consent, fully understands the requirements of the trial and is willing to comply with all trial visits and assessments, including completion of patient-reported measures. Consent must be given before any trial related activities.

Patient is an adult ? 18 years old at the time of informed consent.

Has provided written informed consent

Provision of informed consent

Voluntary signed informed consent before performance of any study-related procedure not part of normal medical care, indicating that that the patient is aware of the investigational nature of the study in keeping with the policies of MD Anderson Cancer Center (MDACC) and with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Eligible to give informed consent to participate in the study.

Voluntary written consent must be given before performance of any study-related procedure

Written informed consent has been obtained

Inability to give informed consent

Voluntary written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent

Voluntary written consent must be given before performance of any study-related procedure

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients must be informed of the investigational nature of this study; patients or a legally authorized representative must sign and give written informed consent in accordance with institutional and federal guidelines

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care.

Written informed consent in accordance with federal, local, and institutional guidelines

Written informed consent in accordance with federal, local, and institutional guidelines

Lack of ability or willingness to give informed consent.

Patients must sign an Informed Consent and Authorization indicating that they are aware of the investigational nature of this study and the known risks involved

All patients must be informed of the investigative nature of the clinical trial and give written informed consent in accordance with institutional and federal guidelines

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Willingness to consent to research biopsy

Patients who give a written informed consent

Written voluntary informed consent: the patient is capable of complying with the requirements of the written Informed Consent Form and complying with protocol requirements

Cognitive impairment sufficient to render the patient incapable of giving informed consent

Written informed consent in accordance with federal, local, and institutional guidelines

Signed written informed consent must be obtained and documented according to International Conference on Harmonisation (ICH) and local regulatory requirements

Written informed consent - a signed informed consent and/or assent (as age appropriate) for study participation including PK sampling will be obtained according to institutional guidelines.

Encephalitis, meningitis, or uncontrolled seizures in the year prior to informed consent

Written informed consent - a signed informed consent and/or assent (as age appropriate) will be obtained according to institutional guidelines.

Diagnostic or laboratory studies performed exclusively to determine eligibility for this trial must only be done after obtaining written informed consent from all patients or their legal guardians (if the patient is < 18 years old); when appropriate, pediatric patients will be included in all discussions; this can be accomplished through one of the following mechanisms: a) the NCI, POB screening protocol, b) an Institutional Review Board (IRB)-approved institutional screening protocol or c) the study-specific protocol; documentation of the informed consent for screening will be maintained in the patient’s research chart; studies or procedures that were performed for clinical indications (not exclusively to determine eligibility) may be used for baseline values even if the studies were done before informed consent was obtained

Unable to give informed consent

All subjects must have the ability to understand and the willingness to sign a written informed consent; only lucid patients qualified to consent to neurosurgical procedure will be approached for participation in this study

Patients must sign an informed consent indicating that they are aware of the investigational nature of this study.

Written informed consent in accordance with federal, local, and institutional guidelines.

Signed informed consent according to institutional guidelines must be obtained; assent, when appropriate, will be obtained according to institutional guidelines

Voluntary written informed consent before performance of any study-related procedure not part of routine medical care with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients must be informed of the investigational nature of this study and must give written informed consent in accordance with institutional and federal guidelines

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Voluntary written consent

Ability to give written informed consent.

Written informed consent.

Voluntary agreement to provide written informed consent and the willingness and ability to comply with all aspects of the protocol.

Written informed consent which is consistent with International Conference on Harmonisation - Good Clinical Practice (ICH-GCP) guidelines and local legislation.

Subjects willing and able to give written informed consent to participate in the study and to adhere to the procedures stated in the protocol, or legally acceptable representative willing and able to give written informed consent on behalf of the subject for minors, unconscious adults and those incapable of consenting themselves due to their medical condition, or included as permitted by local regulatory authorities, IRB/IECs or local laws.

All patients and/or their parents or legal guardians must sign a written informed consent

All patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal regulations

Written informed consent in accordance with federal, local, and institutional guidelines

Capable of given written informed consent, which includes compliance with the requirements and restrictions listed in the consent form.

The patient is >= 18 years of age at the time of signature of the first informed consent form.

Written informed consent and HIPAA authorization for release of personal health information.

Inability to give informed consent

Patient or patient's legal representative, parent(s) or guardian should provide written informed consent; assent of a minor if participant's age is at least seven and less than eighteen years

Patients must give written informed consent

Parental informed consent

Patient or patient's legal representative, parent(s) or guardian should provide written informed consent; assent of a minor if participant's age is at least seven and less than eighteen years

Because significant time will have elapsed between apheresis/tumor biopsy and the initiation of immunotherapy, all patients or their legal guardians (if the patient is < 18 years old) must sign a second informed consent to document their understanding of the investigational nature and the risks of this study before any protocol related studies are performed (other than the studies which were performed to determine patient eligibility)

All patients or their legal guardians (if the patient is < 18 years old) must sign a document of informed consent (screening protocol) prior to performing studies to determine patient eligibility; after confirmation of patient eligibility all patients or their legal guardians must sign the protocol specific informed consent to document their understanding of the investigational nature and the risks of this study before any protocol related studies are performed (other than the studies which were performed to determine patient eligibility)

Inability or unwillingness of research participant or legal guardian or representative to give written informed consent

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must sign an authorization for the release of their protected health information

All patients must sign an informed consent document indicating that they are aware of the investigational nature of this study

Patient has given written informed consent which must be consistent with the International Conference on Harmonization, Good Clinical Practice (ICH-GCP) and local legislation.

Inability or unwillingness of research participant or legal guardian/representative to give written informed consent

Written informed consent following institutional and federal guidelines

The patient is >= 18 years of age at the time of signature of the informed consent form.

Inability to give informed consent because of psychiatric problems, or complicated medical problems.

Provision of written informed consent.

Patients must be capable of signing an informed consent

Written informed consent in accordance with institutional and Food and Drug Administration (FDA) guidelines must be obtained from parent or legal guardian

Written informed consent obtained from subject or subject’s legal representative and ability for subject to comply with requirements of the study

Subjects must have given written informed consent to agree to participate

Documented informed consent of the participant and/or legally authorized representative

Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

All patients and/or their parents or legally authorized representatives must sign a written informed consent; assent, when appropriate, will be obtained according to institutional guidelines

Written informed consent in accordance with federal, local, and institutional guidelines

Subjects must have given written informed consent

Informed consent and Health Insurance Portability and Accountability Act (HIPAA) signing

Voluntary written consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

All patients must be informed of the investigational nature of the study and standard alternative therapies; all patients must sign and give written informed consent in accordance with institutional and federal guidelines

Have the ability to give written informed consent

All patients and/or their parents or legal guardians must sign a written informed consent

Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

All patients and/or their parents or legal guardians must sign a written informed consent (patient assent is also recommended when applicable according to each institution’s policy)

Capable of providing informed consent

Women with cognitive impairment that precludes informed consent and those unable to provide consent in English

Providing informed consent

Willing and able to provide written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information \r\n* NOTE: HIPAA authorization may be either included in the informed consent or obtained separately

All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must sign an authorization for the release of their protected health information